Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1983 Oct;16(4):433–437. doi: 10.1111/j.1365-2125.1983.tb02191.x

Pharmacokinetic observations on piroxicam in young adult, middle-aged and elderly patients.

A D Woolf, H J Rogers, I D Bradbrook, D Corless
PMCID: PMC1428026  PMID: 6626437

Abstract

Nineteen out of 21 patients with painful conditions of the locomotor system aged between 27 and 94 years completed a study in which they received 20 mg piroxicam daily for 14 days. Plasma piroxicam concentrations were estimated by high performance liquid chromatography. Pharmacokinetic analysis of the data showed the half-life and systemic clearance of piroxicam to be unaffected by age. The apparent volume of distribution in older patients was higher than that of younger subjects. Multiple regression analysis showed that creatinine clearance and plasma albumin concentration had insignificant effects on the systemic piroxicam clearance. Although improvement in joint pain and stiffness occurred during the 2 week study period, this could not be correlated with plasma piroxicam concentration.

Full text

PDF
433

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bjornsson T. D., Shand D. G. Estimation of kinetic parameters from a two-point determination of the drug cumulation factor. Clin Pharmacol Ther. 1979 Nov;26(5):540–547. doi: 10.1002/cpt1979265540. [DOI] [PubMed] [Google Scholar]
  2. Cockcroft D. W., Gault M. H. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41. doi: 10.1159/000180580. [DOI] [PubMed] [Google Scholar]
  3. Fleiss J. L. Measuring agreement between two judges on the presence or absence of a trait. Biometrics. 1975 Sep;31(3):651–659. [PubMed] [Google Scholar]
  4. Gibaldi M., Koup J. R. Pharmacokinetic concepts - drug binding, apparent volume of distribution and clearance. Eur J Clin Pharmacol. 1981;20(4):299–305. doi: 10.1007/BF00618781. [DOI] [PubMed] [Google Scholar]
  5. Halsey J. P., Cardoe N. Benoxaprofen: side-effect profile in 300 patients. Br Med J (Clin Res Ed) 1982 May 8;284(6326):1365–1368. doi: 10.1136/bmj.284.6326.1365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hobbs D. C. Pharmacokinetics of piroxicam in man. Eur J Rheumatol Inflamm. 1983;6(1):46–55. [PubMed] [Google Scholar]
  7. Hobbs D. C., Twomey T. M. Piroxicam pharmacokinetics in man: aspirin and antacid interaction studies. J Clin Pharmacol. 1979 May-Jun;19(5-6):270–281. doi: 10.1002/j.1552-4604.1979.tb02480.x. [DOI] [PubMed] [Google Scholar]
  8. Ishizaki T., Nomura T., Abe T. Pharmacokinetics of piroxicam, a new nonsteroidal anti-inflammatory agent, under fasting and postprandial states in man. J Pharmacokinet Biopharm. 1979 Aug;7(4):369–381. doi: 10.1007/BF01062535. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES